Skip to main content

indie Semiconductor, Inc.

For the period ended Sep 30, 2025. Filed Nov 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 7, 2025

INDI$2.28+3.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

(Amounts in thousands)

Nine Months EndedSeptember 30,
20252024
Cash flows from operating activities:
Net loss$(119,483)$(109,818)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization30,41630,872
Amortization of inventory step-up—365
Allowance for credit losses and inventory reserves1,5063,343
Share-based compensation, including restructuring costs50,59855,360
Amortization of discount and cost of issuance of debt2,077788
Asset impairment in relation to restructuring3,231998
Gain from change in fair value of contingent considerations and acquisition-related holdbacks(4,899)(28,167)
Loss (Gain) from change in fair value of currency forward contract(1,294)701
Gain from extinguishment of debt(2,623)—
Amortization of right-of-use assets2,4062,504
Changes in operating assets and liabilities:
Accounts receivable8458,673
Inventory4,890(17,238)
Accounts payable(9,812)7,910
Accrued expenses and other current liabilities(310)(5,064)
Accrued payroll liabilities3,4891,746
Prepaid, other current and noncurrent assets(1,832)(1,332)
Operating lease liabilities(2,236)(2,383)
Other long-term liabilities258(1,135)
Net cash used in operating activities(42,773)(51,877)
Cash flows from investing activities:
Purchases of property and equipment(12,554)(12,504)
Payments for acquired software license—(1,022)
Business combinations, net of cash acquired(17,673)(3,200)
Net cash used in investing activities(30,227)(16,726)
Cash flows from financing activities:
Proceeds from issuance of common stock/At-The-Market offering—13,234
Proceeds from issuance of debt obligations2,84517,194
Issuance costs on line of credit(50)(50)
Payments on debt obligations(3,538)(2,048)
Repurchase of debt obligations(26,829)—
Payments on financed software(5,824)(4,429)
Deferred payments on business combination(2,534)(500)
Proceeds from exercise of stock options453
Net cash provided by (used in) financing activities(35,926)23,454
Effect of exchange rate changes on cash and cash equivalents(4,460)668
Net decrease in cash and cash equivalents(113,386)(44,481)
Cash, cash equivalents and restricted cash at beginning of period284,548151,678
Cash, cash equivalents and restricted cash at end of period$171,162$107,197
Reconciliation of amounts on condensed consolidated balance sheet:
Cash and cash equivalents$160,873$96,897
Restricted cash10,28910,300
Total cash, cash equivalents and restricted cash$171,162$107,197
Supplemental disclosure of cash flow information:
Cash paid for interest$8,124$3,787
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment, accrued but not paid$141$134
Fair value of common stock issued to satisfy contingent considerations and acquisition-related holdbacks$—$49,760
Contingent consideration for business combination$7,287$4,599
Accrual for purchase consideration for business combination$2,970$800
Fair value of common stock issued for investment in Expedera$—$3,428
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.